Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study confirms that Black men are at higher risk for prostate cancer disease progression and death.
Black men had “a significantly higher incidence” of both localized and metastatic prostate cancer. But researchers reported good news too.
Young Black men who received PSA testing more often were 40% less likely to be diagnosed with advanced prostate cancer.
The FDA-approved test determines both whether prostate cancer has metastasized and where those tumor cells can be found.
The benefit of reduced mortality must be balanced against the harms of overdiagnosis.
These men lived for a median of 30 months compared to 26 months for white men.
Studies show African-American men may respond better to treatment and survive longer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.